Literature DB >> 21633525

Mallory-Denk Bodies in chronic hepatitis.

Metin Basaranoglu1, Nesrin Turhan, Abdullah Sonsuz, Gökcen Basaranoglu.   

Abstract

Mallory-Denk Bodies (MDB) are important as investigators, suggesting MDB as an indicator of the histologic severity of chronic hepatitis, causes of which include hepatitis C, primary biliary cirrhosis (PBC), and nonalcoholic fatty liver disease (NAFLD). Matteoni et al scored MDB in patients with NAFLD as none, rare and many, and reported that MDB plays a prominent role in this classification scheme in an earlier classification system. In this study, we evaluated 258 patients with chronic hepatitis due to metabolic, autoimmune and viral etiologies. Liver biopsy samples were evaluated with hematoxylin and eosin, periodic acid-Schiff-diastase, Gordon and Sweet's reticulin, Masson's trichrome, and iron stains. Both staging and grading were performed. Additionally, MDB were evaluated and discussed for each disease. We examined patients with nonalcoholic steatohepatitis (NASH; 50 patients), alcoholic hepatitis (10 patients), PBC (50 patients), Wilson disease (WD; 20 patients), hepatitis B (50 patients), hepatitis C (50 patients) and hepatocellular carcinoma (HCC; 30 patients). Frequency of MDB was as follows; NASH: 10 patients with mild in 60% and moderate in 40% and observed in every stage of the disease and frequently seen in zone 3. PBC: 11 patients with mild in 10%, moderate in 70%, and cirrhosis in 20%, and frequently seen in zone 1. WD: 16 patients with moderate and severe in 60% and cirrhosis in 40% and frequently seen in zone 1. Hep B: 3 patients with mild in 66% and severe in 34%. Hep C: 7 patients with mild in 40% and moderate in 60% and observed in every stage. HCC: 3 patients with hep B in 2 patients. We found that there is no relationship between MDB and any form of chronic hepatitis regarding histologic severity such as alcoholic steatohepatitis and NAFLD and variable zone distribution by etiology.

Entities:  

Keywords:  Hepatitis B and C; Hepatocellular carcinoma; Mallory-Denk Bodies; Non-alcoholic fatty liver disease; Primary biliary cirrhosis; Wilson disease

Mesh:

Substances:

Year:  2011        PMID: 21633525      PMCID: PMC3092867          DOI: 10.3748/wjg.v17.i17.2172

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

Review 1.  Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse.

Authors:  W K Lelbach
Journal:  Ann N Y Acad Sci       Date:  1975-04-25       Impact factor: 5.691

2.  The pathology of diabetic hepatitis.

Authors:  N Nagore; P J Scheuer
Journal:  J Pathol       Date:  1988-10       Impact factor: 7.996

Review 3.  Alcoholic hepatitis.

Authors:  C L Mendenhall
Journal:  Clin Gastroenterol       Date:  1981-05

4.  Heat shock proteins are present in mallory bodies (cytokeratin aggresomes) in human liver biopsy specimens.

Authors:  N E Riley; J Li; L W McPhaul; F Bardag-Gorce; Y H Lue; S W French
Journal:  Exp Mol Pathol       Date:  2003-04       Impact factor: 3.362

5.  Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.

Authors:  S Itoh; T Yougel; K Kawagoe
Journal:  Am J Gastroenterol       Date:  1987-07       Impact factor: 10.864

6.  The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.

Authors:  E E Powell; W G Cooksley; R Hanson; J Searle; J W Halliday; L W Powell
Journal:  Hepatology       Date:  1990-01       Impact factor: 17.425

7.  Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease.

Authors:  M Vyberg; P Leth
Journal:  APMIS Suppl       Date:  1991

8.  Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.

Authors:  A M Diehl; Z Goodman; K G Ishak
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

Review 9.  Nonalcoholic steatohepatitis: a study of 49 patients.

Authors:  R G Lee
Journal:  Hum Pathol       Date:  1989-06       Impact factor: 3.466

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  14 in total

1.  Pediatric non-alcoholic steatohepatitis: the first report on the ultrastructure of hepatocyte mitochondria.

Authors:  Joanna M Lotowska; Maria E Sobaniec-Lotowska; Sylwia B Bockowska; Dariusz M Lebensztejn
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  The inflammasome in alcoholic hepatitis: Its relationship with Mallory-Denk body formation.

Authors:  Yue Peng; Barbara A French; Brittany Tillman; Timothy R Morgan; Samuel W French
Journal:  Exp Mol Pathol       Date:  2014-08-19       Impact factor: 3.362

3.  Alcoholic steatohepatitis (ASH) causes more UPR-ER stress than non-alcoholic steatohepatitis (NASH).

Authors:  M Masouminia; S Samadzadeh; A Ebaee; B A French; B Tillman; S W French
Journal:  Exp Mol Pathol       Date:  2016-08-29       Impact factor: 3.362

4.  Nonalcoholic fatty liver may increase the risk of operation in patients with fatty liver and the frequency of cancer in their first-degree relatives.

Authors:  Metin Basaranoglu; Billur Canbakan; Kemal Yildiz; Bahadir Ceylan; Birol Baysal; Omer Uysal; Hakan Senturk
Journal:  Wien Klin Wochenschr       Date:  2015-04-14       Impact factor: 1.704

5.  Mallory-Denk Body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH).

Authors:  Hui Liu; Ming Gong; Barbara A French; Jun Li; Brittany Tillman; Samuel W French
Journal:  Exp Mol Pathol       Date:  2014-10-05       Impact factor: 3.362

Review 6.  From fatty liver to fibrosis: a tale of "second hit".

Authors:  Metin Basaranoglu; Gökcen Basaranoglu; Hakan Sentürk
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

7.  TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies.

Authors:  Hui Liu; Jun Li; Brittany Tillman; Timothy R Morgan; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2014-07-02       Impact factor: 3.362

8.  Altered regulation of miR-34a and miR-483-3p in alcoholic hepatitis and DDC fed mice.

Authors:  Hui Liu; Barbara A French; Jun Li; Brittany Tillman; Samuel W French
Journal:  Exp Mol Pathol       Date:  2015-09-25       Impact factor: 3.362

9.  Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.

Authors:  Yasushi Horai; Hiroyuki Utsumi; Yuko Ono; Toshimitsu Kishimoto; Yuuichi Ono; Atsushi Fukunari
Journal:  Int J Exp Pathol       Date:  2016-03-31       Impact factor: 1.925

10.  IL-8 signaling is up-regulated in alcoholic hepatitis and DDC fed mice with Mallory Denk Bodies (MDBs) present.

Authors:  Hui Liu; Barbara A French; Tyler J Nelson; Jun Li; Brittany Tillman; Samuel W French
Journal:  Exp Mol Pathol       Date:  2015-08-08       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.